ARTICLE | Product Development
Industry continues to build COVID-19 testing capacity
BioCentury is providing this story for free given the urgent need for information about the COVID-19 crisis. For more analysis, sign up for our daily email.
March 20, 2020 6:45 PM UTC
Updated on Mar 25, 2020 at 10:30 PM UTC
Diagnostics companies are continuing to step up to meet demand for expanded COVID-19 testing capabilities with a range of PCR- and antibody-based tests.
PCR-based tests for COVID-19 detect active infection with SARS-CoV-2, while antibody-based tests detect anti-SARS-CoV-2 antibodies. Given the long-lived nature of antibodies, the latter type of test should also be able to identify individuals who have recovered from infection, including those who never developed symptoms. ...